J&J's Regranex Ups Cancer Mortality Risk: FDA

By Erin Marie Daly (June 9, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration has added its most serious warning to Johnson & Johnson's Regranex after a study indicated that although diabetics who use large amounts of the foot ulcer gel may not be more likely to develop cancer, if they do, they are five times more likely to die of it....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!